These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8345569)

  • 1. Oral absorption and bioavailability of fenbendazole in the dog and the effect of concurrent ingestion of food.
    McKellar QA; Galbraith EA; Baxter P
    J Vet Pharmacol Ther; 1993 Jun; 16(2):189-98. PubMed ID: 8345569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of fenbendazole in dogs.
    McKellar QA; Harrison P; Galbraith EA; Inglis H
    J Vet Pharmacol Ther; 1990 Dec; 13(4):386-92. PubMed ID: 2287030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of fenbendazole following intravenous and oral administration to pigs.
    Petersen MB; Friis C
    Am J Vet Res; 2000 May; 61(5):573-6. PubMed ID: 10803655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of fenbendazole in channel catfish.
    Kitzman JV; Holley JH; Huber WG; Koritz GD; Davis LE; Neff-Davis CA; Bevill RF; Short CR; Barker SA; Hsieh LC
    Vet Res Commun; 1990; 14(3):217-26. PubMed ID: 2382406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenbendazole pharmacokinetics, metabolism, and potentiation in horses.
    McKellar QA; Gokbulut C; Muzandu K; Benchaoui H
    Drug Metab Dispos; 2002 Nov; 30(11):1230-9. PubMed ID: 12386129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.
    Paulson SK; Vaughn MB; Jessen SM; Lawal Y; Gresk CJ; Yan B; Maziasz TJ; Cook CS; Karim A
    J Pharmacol Exp Ther; 2001 May; 297(2):638-45. PubMed ID: 11303053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uptake of fenbendazole by cattle and buffalo following long-term low-level administration in urea-molasses blocks.
    Sanyal PK; Singh DK
    Vet Res Commun; 1993; 17(2):137-42. PubMed ID: 8212523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C; Bilgili A; Hanedan B; McKellar QA
    Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic behaviour of fenbendazole in buffalo and cattle.
    Sanyal PK
    J Vet Pharmacol Ther; 1994 Feb; 17(1):1-4. PubMed ID: 8196087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intravenous and oral pharmacokinetics of lotilaner in dogs.
    Toutain CE; Seewald W; Jung M
    Parasit Vectors; 2017 Nov; 10(1):522. PubMed ID: 29089051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of fenbendazole in the rabbit.
    Short CR; Barker SA; Hsieh LC; Ou SP; McDowell T
    Res Vet Sci; 1988 Mar; 44(2):215-9. PubMed ID: 3387675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levamisole pharmacokinetics and bioavailability in dogs.
    Watson AD; Sangster NC; Church DB; Van Gogh H
    Res Vet Sci; 1988 Nov; 45(3):411-3. PubMed ID: 3212292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bioavailability of febantel in dehydrated camels.
    Ben-Zvi Z; Gussarsky E; van Creveld C; Yagil R
    J Vet Pharmacol Ther; 1996 Aug; 19(4):288-94. PubMed ID: 8866457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of fenbendazole metabolites in buffalo and cattle after long-term intraruminal administration.
    Sanyal PK
    Vet Q; 1993 Dec; 15(4):157-9. PubMed ID: 8122352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
    Guivarc'h PH; Vachon MG; Fordyce D
    Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bioavailability of quercetin from different quercetin glycosides in dogs.
    Reinboth M; Wolffram S; Abraham G; Ungemach FR; Cermak R
    Br J Nutr; 2010 Jul; 104(2):198-203. PubMed ID: 20230651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beagle dog as an animal model for a bioavailability study of controlled-release theophylline under the influence of food.
    Shiu GK; LeMarchand A; Sager AO; Velagapudi RB; Skelly JP
    Pharm Res; 1989 Dec; 6(12):1039-42. PubMed ID: 2622858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of praziquantel, pyrantel embonate, febantel and its active metabolites, oxfendazole and fenbendazole, in dog plasma by liquid chromatography/mass spectrometry.
    Klausz G; Keller É; Sára Z; Székely-Körmöczy P; Laczay P; Ary K; Sótonyi P; Róna K
    Biomed Chromatogr; 2015 Dec; 29(12):1859-65. PubMed ID: 26104502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.